Forte Biosciences (FBRX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts FBRX Hot Sheet
Join SI Premium – FREE
Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- CVG to join Russell 2000 and Russell 3000 indexes June 26
- After-Hours Stock Movers: FDX, CBRS, NKE
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
